Korea Union Pharm Decides on Third-Party Allocation Paid-in Capital Increase Worth 6.9 Billion KRW

Korea Union Pharmaceutical announced on the 30th that it has decided on a third-party allotment paid-in capital increase worth 6.9 billion KRW.

New common shares totaling 1,578,947 shares will be issued at 4,370 KRW per share. The third-party allotment recipient is Union New Technology Business Investment Association.